A detailed history of Cx Institutional transactions in Dexcom Inc stock. As of the latest transaction made, Cx Institutional holds 3,903 shares of DXCM stock, worth $343,776. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,903
Previous 523 646.27%
Holding current value
$343,776
Previous $35,000 765.71%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

BUY
$65.68 - $81.01 $221,998 - $273,813
3,380 Added 646.27%
3,903 $303,000
Q3 2024

Oct 11, 2024

SELL
$64.0 - $116.06 $116,416 - $211,113
-1,819 Reduced 77.67%
523 $35,000
Q2 2024

Jul 11, 2024

SELL
$110.31 - $140.45 $8,273 - $10,533
-75 Reduced 3.1%
2,342 $265,000
Q1 2024

Apr 15, 2024

BUY
$114.22 - $140.1 $12,792 - $15,691
112 Added 4.86%
2,417 $335,000
Q4 2023

Jan 12, 2024

BUY
$75.49 - $124.16 $174,004 - $286,188
2,305 New
2,305 $286,000
Q2 2023

Jul 26, 2023

BUY
$112.47 - $130.98 $11,247 - $13,097
100 Added 4.61%
2,271 $291,000
Q1 2023

May 04, 2023

BUY
$104.0 - $122.92 $225,784 - $266,859
2,171 New
2,171 $252,000
Q2 2022

Aug 02, 2022

BUY
$67.99 - $132.89 $2,515 - $4,916
37 New
37 $3,000
Q4 2021

Jan 18, 2022

SELL
$129.87 - $162.82 $11,558 - $14,490
-89 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$106.71 - $143.18 $2,134 - $2,863
20 Added 28.99%
89 $49,000
Q2 2021

Aug 04, 2021

BUY
$80.99 - $107.93 $3,401 - $4,533
42 Added 155.56%
69 $29,000
Q1 2021

Apr 15, 2021

BUY
$84.79 - $104.74 $169 - $209
2 Added 8.0%
27 $10,000
Q4 2020

Jan 12, 2021

BUY
$78.0 - $104.5 $1,794 - $2,403
23 Added 1150.0%
25 $9,000
Q3 2020

Oct 13, 2020

BUY
$95.51 - $112.95 $191 - $225
2 New
2 $1,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $34B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.